The goal of this clinical trial is to investigate the prevalence of sarcopenia in olderpeople with post-COVID-19 living in Ratchatewi district, Bangkok and to test theeffectiveness of health promotion program for older people with post-COVID-19 Sarcopenia.The main questions it aim to answer are: • How many is the prevalence of sarcopenia inolder people with post-COVID-19 living in Ratchatewi district, Bangkok? • Can the healthpromotion program improve muscle mass and muscle strength in older people withpost-COVID-19 Sarcopenia ? Participants will be asked eating protein supplement one scoop/day and exercising 2 times/week for 3 months.
Not Provided
Other: Protein powder and Resistance exercise
1. Protein powder supplementation 25-30 g/day
2. Resistance exercise 2 time/week
Inclusion Criteria:
- Older people with post-COVID-19 sarcopenia aged more than and equal 60 years
- No disabilities
- Able to read, write and communicate Thai langue
- Live in Bangkok
- Moderate post-covid-19 state defined by Thai version of the COVID-19 Yorkshire
Rehabilitation Scale
- No soy protein allergy
- Sign inform consent
Exclusion Criteria:
- Severe post-covid-19 state defined by Thai version of the COVID-19 Yorkshire
Rehabilitation Scale and complicated health problems
- Disabilities
- Unable to read, write and communicate Thai langue
- Soy protein allergy
- CKD 4 and CKD 5
- Deny or withdraw from project
Not Provided
Wanabhorn Tongchom, Doctoral
022012652
wanabhorntc@gmail.com
Not Provided